NX vs WST · rev $1.37B vs P/E 35, rev $1.72B
Quanex Building Products (NX) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Quanex Building Products (NX) is a building products & equipment company listed on NYSE.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported NX revenue for 2026-07-31 was $1.37B. Net income was $25.8M. Revenue was up 57.6% from 2026-04-30 to 2026-07-31. NX currently screens at market cap $743.1M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
NX currently screens at market cap $743.1M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the NX and WST stock pages for the full models.
Not investment advice.